Molecular Determinants of Gastrointestinal and Liver Cancers: Role of Bile Acid Activated Nuclear Receptors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|12|6|625-636

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.6, 2012-03, pp. : 625-636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bile Acid Derivatives as Ligands of the Farnesoid X Receptor: Molecular Determinants for Bile Acid Binding and Receptor Modulation

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2159-2174

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-Activated Nuclear Receptors and Sepsis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 3, 2010-09 ,pp. : 258-265

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand Recognition by Drug-Activated Nuclear Receptors PXR and CAR: Structural, Site-Directed Mutagenesis and Molecular Modeling Studies

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 937-943

Bentham Science Publishers

Access to resources Recommend Favorite

Observations on the epidemiology of gastrointestinal and liver cancers in the Asia–Pacific region

By  

Journal of Digestive Diseases, Vol. 15, Iss. 9, 2014-09 ,pp. : 463-468

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apoptosis-Induction is A Novel Therapeutic Strategy for Gastrointestinal and Liver Cancers

By  

Current Gene Therapy, Vol. 15, Iss. 2, 2015-01 ,pp. : 193-200

Bentham Science Publishers

Access to resources Recommend Favorite